Advances and Challenges in the Classification of Childhood Arthritis
DOI:
https://doi.org/10.12974/2311-8687.2023.11.16Keywords:
Juvenile idiopathic arthritis, Childhood arthritis, Pediatric rheumatology, ClassificationAbstract
The most appropriate classification of childhood arthritis remains controversial. Several efforts have been made over the years to devise classification systems that identify homogeneous subgroups within the disease spectrum. Although widely used, the International League of Associations for Rheumatology (ILAR) classification has shown major limitations as it was found to have failed its primary goal of identifying homogeneous disease categories. Furthermore, its use of the count of affected joints and of the presence of psoriatic features to define individual disease subsets has been criticized. A novel classification system has been proposed by the Pediatric Rheumatology International Trials Organization (PRINTO) through expert consensus. The preliminary scheme is currently being scrutinized by means a large-scale data collection aimed to formulate an evidence-based classification, whose results will likely be available in 2024. The development of a clinicobiologic classification has been tried in a proof-of-concept study by integrating meaningful biologic and clinical characteristics, including levels of proinflammatory cytokines and measures of disease activity, that defined indicators or composite variables capable of identifying homogeneous patient subgroups by cluster analysis. The current advance in biotechnology, especially genomics, proteomics and transcriptomics, may pave the way to the future identification of well-defined clusters of patients that will inform a biology-based and data-driven classification system. However, any attempt to defining biologic subtypes should be combined with precise clinical and prognostic data in order to devise a rational classification that facilitates the progress towards personalized management of children with JIA. Furthermore, the observed variability in the prevalence of disease subtypes across geographic areas and ethnic groups must be taken into account to develop a classification that is applicable on a global scale.
References
Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, et al.: Current proposed revision of JRA criteria. Arthritis Rheum 1977; 20 (Suppl. 2): 195-9.
Wood P: Special Meeting on: nomenclature and classification of arthritis in children. In: Munthe E (Ed.) The Care of Rheumatic Children. EULAR Publisher, Basle, 1987: 47-50.
Rosenberg AM, Petty RE. A syndrome of seronegative enthesopathy and arthropathy in children. Arthritis Rheum 1982; 25: 1041-7. https://doi.org/10.1002/art.1780250902 DOI: https://doi.org/10.1002/art.1780250902
Fink CW. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J Rheumatol 1995; 22: 1566-9.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31(2): 390-2.
Petty RE, Southwood TR, Baum J, E Bhettay, D N Glass, P Manners, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991-4.
Foeldvari I, Bidde M. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology. J Rheumatol 2000; 27: 1069-72.
Merino R, de Inocencio J, Garcia-Consuegra J. Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001). J Rheumatol 2005; 32: 559-61.
Martini A. Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis? J Rheumatol 2003; 30: 1900-3.
Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum 2005; 52: 826-32. https://doi.org/10.1002/art.20945 DOI: https://doi.org/10.1002/art.20945
Duffy CM, Colbert RA, Laxer RM, Schanberg LE, Bowyer SL. Nomenclature and classification in chronic childhood arthritis: time for a change? Arthritis Rheum. 2005; 52(2): 382-5.
https://doi.org/10.1002/art.20815 DOI: https://doi.org/10.1002/art.20815
Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 267-75. https://doi.org/10.1002/art.30076 DOI: https://doi.org/10.1002/art.30076
Martini A. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis. 2012; 71(9): 1437-9. https://doi.org/10.1136/annrheumdis-2012-201388 DOI: https://doi.org/10.1136/annrheumdis-2012-201388
Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology (Oxford) 2005; 44: 1350-3. https://doi.org/10.1093/rheumatology/keh710 DOI: https://doi.org/10.1093/rheumatology/keh710
Semeraro-Rossi L, Koné-Paut I. Is Still's disease an autoinflammatory syndrome?
Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19; 424-430.
Magni-Manzoni S, Epis O, Ravelli A, Klercy C, Visconti C, Lanni S, et al. Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 1497-504. https://doi.org/10.1002/art.24823 DOI: https://doi.org/10.1002/art.24823
Ravelli A, Consolaro A, Schiappapietra B, Martini A The conundrum of juvenile psoriatic arthritis. Clin Exp Rheumatol 2015; 33: S40-S43.
Stoll ML, Mellins ED. Psoriatic arthritis in childhood: a commentary on the controversy. Clin Immunol 2020; 214: 108396. https://doi.org/10.1016/j.clim.2020.108396 DOI: https://doi.org/10.1016/j.clim.2020.108396
Martini A, Ravelli A, Avcin T, Beresford MW, Burgos-Vargas R, Cuttica R, et al. Toward new classification criteria for juvenile idiopathic arthritis: First steps, Pediatric Rheumatology International Trials Organization international consensus. J Rheumatol 2019; 46: 190-7. https://doi.org/10.3899/jrheum.180168 DOI: https://doi.org/10.3899/jrheum.180168
Lee JJY, Eng SWM, Guzman J, Duffy CM, Tucker LB, Oen K, et al. A Comparison of International League of Associations for Rheumatology and Pediatric Rheumatology International Trials Organization Classification Systems for Juvenile Idiopathic Arthritis Among Children in a Canadian Arthritis Cohort. Arthritis Rheumatol 2022; 74: 1409-19. https://doi.org/10.1002/art.42113 DOI: https://doi.org/10.1002/art.42113
Nigrovic PA, Colbert RA, Holers VM, Ozen S, Ruperto N, Thompson SD, et al. Biological classification of childhood arthritis: roadmap to a molecular nomenclature. Nat Rev Rheumatol 2021; 17: 257-69. https://doi.org/10.1038/s41584-021-00590-6 DOI: https://doi.org/10.1038/s41584-021-00590-6
Eng SW, Duong TT, Rosenberg AM, Morris Q, Yeung RS. The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis. Arthritis Rheumatol 2014; 66: 3463-75. https://doi.org/10.1002/art.38875 DOI: https://doi.org/10.1002/art.38875
Ruperto N, Martini A. Current and future perspectives in the management of juvenile idiopathic arthritis. Lancet Child Adolesc Health 2018; 2: 360-70. https://doi.org/10.1016/S2352-4642(18)30034-8 DOI: https://doi.org/10.1016/S2352-4642(18)30034-8
Nigrovic PA, Raychaudhuri S, Thompson SD. Review: Genetics and the Classification of Arthritis in Adults and Children. Arthritis Rheumatol. 2018; 70(1): 7-17. https://doi.org/10.1002/art.40350 DOI: https://doi.org/10.1002/art.40350
Yeung RSM. What's in a Name? That Which We Call JIA, by Any Other Name, Would It Still Be the Same Childhood Arthritis? J Rheumatol 2023; 50 (Suppl. 1): 2-6. https://doi.org/10.3899/jrheum.2023-0458 DOI: https://doi.org/10.3899/jrheum.2023-0458
Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health 2019; 3: 255-263. https://doi.org/10.1016/S2352-4642(19)30027-6 DOI: https://doi.org/10.1016/S2352-4642(19)30027-6
